Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romy de Laat-Kremers

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Journal of Thrombosis and Haemostasis : JTH|July 24, 2024
"Prothrombin conversion and thrombin decay in patients with cirrhosis-role of prothrombin and antithrombin deficiencies": comment from de Laat-Kremers et alRomy de Laat-Kremers, Bas de Laat
Journal of Thrombosis and Haemostasis : JTH|September 27, 2025
Effects of hormonal therapy on thrombin generation testing in transgender individualsMarisa Ninivaggi, Bas de Laat, Romy de Laat-Kremers
Frontiers in Cardiovascular Medicine|April 17, 2023
Editorial: Advances in thrombin generationRomy de Laat-Kremers, Stéphane Zuily, Bas de Laat
Frontiers in Cardiovascular Medicine|December 16, 2024
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein CMarisa Ninivaggi, Lily Sokolova, Demy Donkervoort, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Assessing the individual roles of FII, FV, and FX activity in the thrombin generation processCuicui Bai, Joke Konings, Marisa Ninivaggi, et al.
Frontiers in Cardiovascular Medicine|August 12, 2022
Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assayAudrey Carlo, Qiuting Yan, Hugo Ten Cate, et al.
Frontiers in Immunology|December 27, 2024
Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndromeRomy de Laat-Kremers, Shengshi Huang, Hugo Ten Cate, et al.
Frontiers in Immunology|October 17, 2022
Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98Romy de Laat-Kremers, Raf De Jongh, Marisa Ninivaggi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2021
Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesMarisa Ninivaggi, Romy de Laat-Kremers, Armando Tripodi, et al.
Thrombosis Research|January 10, 2024
High alpha-2-macroglobulin levels are a risk factor for cardiovascular disease events: A Moli-sani cohort studyRomy de Laat-Kremers, Simona Costanzo, Qiuting Yan, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Journal of Thrombosis and Haemostasis : JTH|July 24, 2024
"Prothrombin conversion and thrombin decay in patients with cirrhosis-role of prothrombin and antithrombin deficiencies": comment from de Laat-Kremers et alRomy de Laat-Kremers, Bas de Laat
Journal of Thrombosis and Haemostasis : JTH|September 27, 2025
Effects of hormonal therapy on thrombin generation testing in transgender individualsMarisa Ninivaggi, Bas de Laat, Romy de Laat-Kremers
Frontiers in Cardiovascular Medicine|April 17, 2023
Editorial: Advances in thrombin generationRomy de Laat-Kremers, Stéphane Zuily, Bas de Laat
Frontiers in Cardiovascular Medicine|December 16, 2024
Thrombomodulin is a stronger indicator of combined oral contraceptives-induced activated protein C pathway resistance in the thrombin generation test than activated protein CMarisa Ninivaggi, Lily Sokolova, Demy Donkervoort, et al.
Frontiers in Cardiovascular Medicine|October 7, 2022
Assessing the individual roles of FII, FV, and FX activity in the thrombin generation processCuicui Bai, Joke Konings, Marisa Ninivaggi, et al.
Frontiers in Cardiovascular Medicine|August 12, 2022
Semi-automated thrombin dynamics applying the ST Genesia thrombin generation assayAudrey Carlo, Qiuting Yan, Hugo Ten Cate, et al.
Frontiers in Immunology|December 27, 2024
Interpreting high levels of unfolded Von Willebrand Factor in patients with the antiphospholipid syndromeRomy de Laat-Kremers, Shengshi Huang, Hugo Ten Cate, et al.
Frontiers in Immunology|October 17, 2022
Coagulation parameters predict COVID-19-related thrombosis in a neural network with a positive predictive value of 98Romy de Laat-Kremers, Raf De Jongh, Marisa Ninivaggi, et al.
Journal of Thrombosis and Haemostasis : JTH|April 21, 2021
Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid AntibodiesMarisa Ninivaggi, Romy de Laat-Kremers, Armando Tripodi, et al.
Thrombosis Research|January 10, 2024
High alpha-2-macroglobulin levels are a risk factor for cardiovascular disease events: A Moli-sani cohort studyRomy de Laat-Kremers, Simona Costanzo, Qiuting Yan, et al.
Pageof 2